These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22247846)

  • 1. Formulation and evaluation of s-(-)-amlodipine besylate and nebivolol hydrochloride tablets.
    Shaikh SA; Shaikh SS; Shahi SR; Shookur MA; Reddy LK; Padalkar AN; Thube M
    J Adv Pharm Technol Res; 2010 Apr; 1(2):199-206. PubMed ID: 22247846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous estimation of amlodipine besylate and nebivolol hydrochloride in tablet dosage forms by reverse phase-high-performance liquid chromatographic using ultraviolet detection.
    Sharma D; Jain A; Shrivastava A
    Pharm Methods; 2011 Jan; 2(1):9-14. PubMed ID: 23781423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-derivative synchronous spectrofluorimetric determination of nebivolol hydrochloride and amlodipine besylate in their combined dosage form.
    Ibrahim F; El-Enany N; Shalan SH; Abo Shabana RA
    Luminescence; 2015 Nov; 30(7):1011-9. PubMed ID: 25727077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of chirality on the development of robust and stable tablet formulation of (S-) amlodipine besylate.
    Hadžidedić S; Uzunović A; Sehić Jazić S; Kocova El-Arini S
    Pharm Dev Technol; 2014 Dec; 19(8):930-41. PubMed ID: 24099553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of analytical greenness metric for an eco-friendly method developed through the integration of green chemistry and quality-by-design for the simultaneous determination of Nebivolol hydrochloride, Telmisartan, Valsartan, and Amlodipine besylate.
    Veerendra YVS; Brahman PK; Mankumare SD; Ch J; C VK
    Heliyon; 2024 Aug; 10(16):e35376. PubMed ID: 39220975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety profiles of a new S(-)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: an 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial.
    Kim SA; Park S; Chung N; Lim DS; Yang JY; Oh BH; Tahk SJ; Ahn TH
    Clin Ther; 2008 May; 30(5):845-57. PubMed ID: 18555932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets.
    Azmi NHS; Ming LC; Uddin ABMH; Sarker ZI; Bin LK
    Int J Pharm Compd; 2022; 26(1):80-87. PubMed ID: 35081048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form.
    Vojta J; Jedlička A; Coufal P; Janečková L
    J Pharm Biomed Anal; 2015 May; 109():36-44. PubMed ID: 25756663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability-indicating RP-HPLC method development and validation for the quantification of amlodipine besylate and valsartan tablets in solid oral dosage form.
    Kamireddy T; Sambu P; Lankalapalli PK; Myneni RK; Divadari H
    Biomed Chromatogr; 2024 Dec; 38(12):e6017. PubMed ID: 39327221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteers.
    Liu Y; Jia J; Liu G; Li S; Lu C; Liu Y; Yu C
    Clin Ther; 2009 Apr; 31(4):777-83. PubMed ID: 19446150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemometric spectrophotometric methods for simultaneous estimation of metoprolol succinate and amlodipine besylate in their tablet formulation.
    Kamal AH; Hammad SF; Kamel DN
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Jun; 254():119641. PubMed ID: 33711776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of pullulan-based orally disintegrating films containing amlodipine besylate.
    Pezik E; Gulsun T; Sahin S; Vural İ
    Eur J Pharm Sci; 2021 Jan; 156():105597. PubMed ID: 33065224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of pedal edema during treatment with S(-)-amlodipine nicotinate versus amlodipine besylate in female Korean patients with mild to moderate hypertension: a 12-week, multicenter, randomized, double-blind, active-controlled, phase IV clinical trial.
    Oh GC; Lee HY; Kang HJ; Zo JH; Choi DJ; Oh BH
    Clin Ther; 2012 Sep; 34(9):1940-7. PubMed ID: 22925988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Evaluation of Feline Tailored Amlodipine Besylate Mini-Tablets Using L-lysine as a Candidate Flavouring Agent.
    Ekweremadu CS; Abdelhakim HE; Craig DQM; Barker SA
    Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 32987962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method development and validation of HPLC tandem/mass spectrometry for quantification of perindopril arginine and amlodipine besylate combination in bulk and pharmaceutical formulations.
    Duraisamy K; Jaganathan KS; Krishna MV
    Res Pharm Sci; 2017 Aug; 12(4):307-314. PubMed ID: 28855942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of a switch to fixed-dose combination therapy with amlodipine besylate/benazepril hydrochloride after monotherapy with amlodipine besylate: Data from the African-American subpopulation of a practice-based, open-label study (the LOGIC study).
    Gatlin M; Jarrett WG; Nwose OM;
    Curr Ther Res Clin Exp; 2004 Mar; 65(2):138-48. PubMed ID: 24936113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation development and in vitro characterization of triple layer tablet containing amlodipine besylate, rosuvastatin calcium and hydrochlorothiazide.
    Shah PA; Zaidi HA; Syed HK; Ishfaq H; Altaf RM; Pervaiz A; Khan SU; Iqbal MS; Khan J
    Pak J Pharm Sci; 2021 Mar; 34(2(Supplementary)):699-710. PubMed ID: 34275805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed Dose Single Tablet Formulation with Differential Release of Amlodipine Besylate and Simvastatin and Its Pharmacokinetic Profile: QbD and Risk Assessment Approach.
    Kanwal U; Mukhtar S; Waheed M; Mehreen A; Abbas N; Shamim R; Hussain K; Rasool F; Hussain A; Bukhari NI
    Drug Des Devel Ther; 2021; 15():2193-2210. PubMed ID: 34079222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous Determination of Amlodipine and Irbesartan in their Pharmaceutical Formulations by Square-Wave Voltammetry.
    Palabıyık İM; Dogan A; Süslü İ
    Comb Chem High Throughput Screen; 2022; 25(2):241-251. PubMed ID: 33475067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt.
    Graves RA; Mandal TK; Bostanian LA; Nguyen AT; Swopes D; Morris TC; Pramar YV
    Int J Pharm Compd; 2019; 23(6):519-527. PubMed ID: 31751949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.